Douglass Brian Robb reported RGEN

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001628280-26-065462

Machine-readable

Structured copy

Timestamps

Event (reported)

Oct 6, 2026

Published

Oct 8, 2026

Ingested by INSIDER

Nov 5, 02:12 UTC

Last re-read

Nov 5, 02:12 UTC

Extracted facts

Filer

Douglass Brian Robb

Role

CHIEF PRODUCT OFFICER

Transaction

Grant or awardAs filed: “A”

Asset

REPLIGEN CORP — Stock Option (Right to Buy)

Ticker

RGEN

Shares

675

Price per share

$0

Execution date (reported)

Oct 6, 2026

Owned after transaction

675 shares

Days from execution to publication

2

What this establishes

Douglass Brian Robb filed this Form 4 reporting a grant or award of RGEN on Oct 6, 2026. It became public on Oct 8, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

CHIEF PRODUCT OFFICER

Douglass Brian Robbcik:0002104618

Issuer

REPLIGEN CORPcik:0000730272

Revision history · 0

No field has changed since this record was first ingested.